Tonix Pharmaceuticals Holding Corp.
(NASDAQ : TNXP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -4.52%48.580.0%$711.87m
GWPHGW Pharmaceuticals Plc -0.28%214.256.1%$393.29m
HZNPHorizon Therapeutics Plc 0.38%90.915.5%$197.75m
JAZZJazz Pharmaceuticals Plc -1.58%168.042.3%$189.90m
VRXValeant Pharmaceuticals International, Inc. 0.58%31.4614.1%$185.11m
BHCBausch Health Cos., Inc. 0.58%31.460.0%$141.41m
CTLTCatalent, Inc. 1.07%113.452.1%$115.20m
ICLRICON plc -2.04%180.684.2%$96.12m
ARGXargenx SE -2.59%330.680.0%$81.80m
PRGOPerrigo Co. Plc -1.64%40.116.8%$71.31m
TNXPTonix Pharmaceuticals Holding Corp. -2.46%1.190.2%$66.62m
ZYNEZynerba Pharmaceuticals, Inc. 0.79%4.506.0%$58.84m
AMRNAmarin Corp. Plc -3.02%6.741.5%$49.30m
UTHRUnited Therapeutics Corp. -0.96%167.1814.1%$44.01m
PBHPrestige Consumer Healthcare, Inc. 0.12%41.824.0%$40.75m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.